Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01737762 · ClinicalTrials.gov registry record · Phase 3
Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2
A Phase 3 study, sponsored by Healthpoint.
- Completed
- Registry status
- Phase 3
- Development phase
- 155
- Enrollment target
NCT01737762 is a Phase 3 study that has completed, run by Healthpoint. The registered enrollment target is 155 participants.
The verdict
NCT01737762, a Phase 3 study, has completed, sponsored by Healthpoint.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 155 participants
- Enrollment target
Study Summary
This study is being done to find out if an investigational product called HP802-247 can help people with venous leg ulcers. Investigational means that HP802-247 has not been approved by the U.S. Food and Drug Administration (FDA). At least 250 subjects will participate. The study is going to be conducted in approximately 50 sites in the United States and Canada.
Interventions
- BIOLOGICAL Vehicle
- BIOLOGICAL HP802-247
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2012-11 |
| Est. Completion | 2015-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01737762
The ClinicalTrials.gov registry entry for NCT01737762 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 155 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Healthpoint, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle is the first listed.
NCT01737762 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01737762 about?
NCT01737762 is a clinical study titled "Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2". This study is being done to find out if an investigational product called HP802-247 can help people with venous leg ulcers. Investigational means that HP802-247 has not been approved by the U.S. Food and Drug Administration (FDA). At least 250 subjects will participate. The study is going to be con...
What is the current status of trial NCT01737762?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 155 participants. The study started on 2012-11. Estimated completion is 2015-11.
What interventions are being tested in trial NCT01737762?
The interventions under investigation include: Vehicle (BIOLOGICAL), HP802-247 (BIOLOGICAL).
Who is sponsoring clinical trial NCT01737762?
This trial is sponsored by Healthpoint, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.